Total Payments
$25,991
2024 Payments
$5,834
Companies
21
Transactions
170
Medicare Patients
751
Medicare Billing
$68,155
Payment Breakdown by Category
Other$21,225 (81.7%)
Food & Beverage$4,386 (16.9%)
Consulting$300.00 (1.2%)
Education$80.21 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,225 | 14 | 81.7% |
| Food and Beverage | $4,386 | 151 | 16.9% |
| Consulting Fee | $300.00 | 2 | 1.2% |
| Education | $80.21 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $21,696 | 39 | $0 (2024) |
| Allergan, Inc. | $926.57 | 20 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $579.60 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $424.45 | 26 | $0 (2020) |
| Amgen Inc. | $320.42 | 5 | $0 (2020) |
| Alkermes, Inc. | $300.00 | 2 | $0 (2017) |
| Lilly USA, LLC | $224.23 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $216.80 | 3 | $0 (2021) |
| Lundbeck LLC | $191.82 | 20 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $179.49 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,834 | 10 | ABBVIE INC. ($5,577) |
| 2023 | $6,759 | 16 | AbbVie Inc. ($6,395) |
| 2022 | $6,942 | 20 | ABBVIE INC. ($6,504) |
| 2021 | $3,409 | 28 | AbbVie Inc. ($3,220) |
| 2020 | $534.31 | 38 | Allergan, Inc. ($210.37) |
| 2019 | $1,133 | 35 | Allergan Inc. ($257.75) |
| 2018 | $1,012 | 19 | Allergan Inc. ($439.28) |
| 2017 | $367.25 | 4 | Alkermes, Inc. ($300.00) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $80.97 | General |
| 05/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $117.54 | General |
| Category: PSYCHIATRY | ||||||
| 05/31/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $111.64 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.01 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 148 | $17,516 | $5,819 |
| 2022 | 3 | 54 | 131 | $19,104 | $6,523 |
| 2021 | 5 | 215 | 325 | $52,305 | $16,754 |
| 2020 | 7 | 442 | 728 | $109,391 | $39,059 |
Total Patients
751
Total Services
1,332
Medicare Billing
$68,155
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 56 | $10,524 | $3,388 | 32.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 18 | 92 | $6,992 | $2,431 | 34.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 63 | $10,813 | $3,649 | 33.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $4,415 | $1,499 | 34.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 13 | 51 | $3,876 | $1,375 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 111 | $20,868 | $6,042 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 67 | $11,681 | $3,978 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 86 | $11,008 | $3,567 | 32.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $5,632 | $2,167 | 38.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 11 | 41 | $3,116 | $999.55 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 254 | $47,752 | $17,483 | 36.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 164 | 288 | $36,864 | $12,225 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 62 | $10,546 | $3,346 | 31.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 25 | 25 | $7,225 | $2,738 | 37.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 54 | 57 | $3,156 | $1,960 | 62.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 14 | 16 | $1,872 | $740.27 | 39.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 25 | 26 | $1,976 | $566.80 | 28.7% |
About Dr. Ramesh Shivani, MD
Dr. Ramesh Shivani, MD is a Psychiatry healthcare provider based in Hillsboro, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477545390.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Shivani, MD has received a total of $25,991 in payments from pharmaceutical and medical device companies, with $5,834 received in 2024. These payments were reported across 170 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,225).
As a Medicare-enrolled provider, Shivani has provided services to 751 Medicare beneficiaries, totaling 1,332 services with total Medicare billing of $68,155. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Hillsboro, OH
- Active Since 08/17/2005
- Last Updated 02/07/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1477545390
Products in Payments
- VRAYLAR (Drug) $22,500
- REXULTI (Drug) $706.59
- Aimovig (Biological) $320.42
- AJOVY (Drug) $205.91
- LATUDA (Drug) $179.49
- CAPLYTA (Drug) $168.10
- Auvelity (Drug) $166.36
- INGREZZA (Drug) $157.82
- AUSTEDO (Drug) $153.11
- UBRELVY (Drug) $122.82
- NUEDEXTA (Drug) $121.17
- INVEGA SUSTENNA (Drug) $112.35
- INBRIJA (Drug) $107.00
- SPRAVATO (Drug) $104.45
- AJOVY (Biological) $65.43
- BRINTELLIX (Drug) $64.83
- Veltassa (Drug) $48.08
- GIAPREZA (Drug) $38.40
- EMGALITY (Drug) $30.29
- Zembrace (Drug) $14.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Hillsboro
Dipika Shah, Md, MD
Psychiatry — Payments: $1,635
Psychiatry $1,635
Dr. Jennifer Scott, Md, MD
Psychiatry — Payments: $326.87
Psychiatry $326.87
Chinenyenwa Onyemaechi, Md, MD
Psychiatry — Payments: $207.00
Psychiatry $207.00
Lydia Fazzio, M.d, M.D
Psychiatry — Payments: $110.89
Psychiatry $110.89
Christine Arthur, M.d, M.D
Psychiatry — Payments: $90.67
Psychiatry $90.67
Yassmin Atefi, Do, DO
Psychiatry — Payments: $52.98
Psychiatry $52.98